Use of aluminium hydroxide and calcium phosphate as delivery molecules for TGF-β1

被引:0
|
作者
Ucan, U. S. [1 ]
Yildirim, S.
Simsek, A.
Ortatatli, M.
Erganis, O.
机构
[1] Selcuk Univ, Dept Microbiol & Immunol, Fac Vet Med, TR-42025 Konya, Turkey
[2] Selcuk Univ, Dept Virol, Fac Vet Med, TR-42025 Konya, Turkey
[3] Selcuk Univ, Dept Pathol, Fac Vet Med, TR-42025 Konya, Turkey
来源
INDIAN VETERINARY JOURNAL | 2007年 / 84卷 / 04期
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Transforming Growth Factor-beta(1) (TGF - beta(1))'s mitogenic activities have been documented to some extent in dentinogenesis and wound healing. However, TGF as a therapeutical agent has not been considered neither in veterinary nor in medical dentistry so far. In order to examine this, it is first necessary. to incorporate the cytokine to a slow delivery system and then to show its various effects on different types of cells. The present study was designed to evaluate the properties of two different adjuvants, aluminium hydroxide (AH) and calcium phosphate (CP), as delivery substances for recombinate human TGF-beta(1).
引用
收藏
页码:356 / 358
页数:3
相关论文
共 50 条
  • [1] TGF-β1 alone and in combination with calcium hydroxide is synergistic to TGF-β1 production by osteoblasts in vitro
    Jaunberzins, A
    Gutmann, JL
    Witherspoon, DE
    Harper, RP
    INTERNATIONAL ENDODONTIC JOURNAL, 2000, 33 (05) : 421 - 426
  • [2] TGF-β1 calcium signaling in osteoblasts
    Nesti, Leon J.
    Caterson, E. J.
    Li, Wan-Ju
    Chang, Richard
    McCann, Thane D.
    Hoek, Jan B.
    Tuan, Rocky S.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (02) : 348 - 359
  • [3] USE OF CALCIUM HYDROXIDE AND BICALCIUM PHOSPHATE IN EXTRUDED PRODUCTS
    RAOUL, Y
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1991, 175 (08): : 1271 - 1271
  • [4] The effect of N-acetylcysteine and calcium hydroxide on TNF-α and TGF-β1 in lipopolysaccharide-activated macrophages
    Karapinar, Senem Pinar
    Ulum, Yeliz Zulfiye Akkaya
    Ozcelik, Bahar
    Buzoglu, Hatice Dogan
    Ceyhan, Deniz
    Peynircioglu, Banu Balci
    Aksoy, Yasemin
    ARCHIVES OF ORAL BIOLOGY, 2016, 68 : 48 - 54
  • [5] Capture immunoassays specific for TGF-Β1 and TGF-Β2. Use in pharmacokinetic studies
    Dasch, J.R.
    Waegell, W.O.
    Carroll, K.
    Pace, D.R.
    Ellingsworth, L.E.
    Annals of the New York Academy of Sciences, 1990, 593
  • [6] Effect of Calcium Silicate-Based Intracanal Medicament and Calcium Hydroxide on Growth Factor TGF-β1 Release from Root Canal Dentine
    Bilvinaite, Goda
    Drukteinis, Saulius
    Simoliunas, Egidijus
    Widbiller, Matthias
    Sakirzanovas, Simas
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2024, 15 (06)
  • [7] The formation of tertiary dentin after pulp capping with a calcium phosphate cement, loaded with PLGA microparticles containing TGF-β1
    Zhang, Weibo
    Walboomers, X. Frank
    Jansen, John A.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2008, 85A (02) : 439 - 444
  • [8] Physicochemical regulation of TGF and VEGF delivery from mesoporous calcium phosphate bone substitutes
    Moller-Siegert, Janina
    Parmentier, Julien
    Laquerriere, Patrice
    Ouadi, Ali
    Raissle, Olivier
    Jallot, Edouard
    Nedelec, Jean-Marie
    Vix-Guterl, Cathie
    Anselme, Karine
    NANOMEDICINE, 2017, 12 (15) : 1835 - 1850
  • [9] Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties
    Goto, N
    Kato, H
    Maeyama, J
    Shibano, M
    Saito, T
    Yamaguchi, J
    Yoshihara, S
    VACCINE, 1997, 15 (12-13) : 1364 - 1371
  • [10] TGF-β1-siRNA delivery with nanoparticles inhibits peritoneal fibrosis
    H Yoshizawa
    Y Morishita
    M Watanabe
    K Ishibashi
    S Muto
    E Kusano
    D Nagata
    Gene Therapy, 2015, 22 : 333 - 340